MeSH D004806 - ependymoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Carmustine | Carmustine | 2022-12-27 | |||
| Alembic Pharmaceuticals | Carmustine | Carmustine | 2023-10-20 | |||
| Amneal Pharmaceuticals | Carmustine | Carmustine | 2018-10-16 | |||
| Avet Lifesciences | Carmustine | Bicnu | 1982-01-01 | |||
| Azurity | Carmustine | Gliadel | 1996-09-23 | |||
| Dr Reddys Laboratories | Carmustine | Carmustine | 2020-10-22 | |||
| Jiangsu Hengrui Medicine | Carmustine | Carmustine | 2021-03-12 | |||
| medac | Carmustine | Carmustine medac (previously Carmustine Obvius) | 2018-07-18 | |||
| Meitheal Pharmaceuticals | Carmustine | Carmustine | 2021-08-02 | |||
| MSN Laboratories | Carmustine | Carmustine | 2023-05-11 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
37%19/52
Phase 2
11%6/54
Phase 3
9%1/11
Approved: 1Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use